| Structure of full-length CD20 in complex with Ofatumumab Fab | |
Heteromer
| 41-218 | 100 | 6×Y01; |
|
| CryoEM structure of CD20 in complex with engineered conformationally rigid Rituximab.4DS Fab | |
Heteromer
| 46-219 | 100.0 | |
|
| CryoEM structure of CD20 in complex with wild type Rituximab Fab | |
Heteromer
| 46-219 | 100.0 | |
|
| Structure of full-length CD20 in complex with Rituximab Fab | |
Heteromer
| 45-216 | 100 | 8×Y01; 2×PC1; 10×MYS; |
|
| Structure of full-length CD20 in complex with Obinutuzumab Fab | |
Heteromer
| 45-213 | 100 | |
|
| Structure of full-length CD20 in complex with Obinutuzumab Fab | |
Heteromer
| 45-213 | 100 | |
|
| Structure of CD20 in complex with rituximab Fab | |
Heteromer
| 46-210 | 100 | 6×Y01; |
|
| Epitope characterization and crystal structure of GA101 provide insights into the molecular basis f… | |
Heteromer
| 164-187 | 100 | 1×CL; |
|
| Crystal structure of Rituximab Fab in complex with an epitope peptide | |
Heteromer
| 167-186 | 100 | |
|
| Crystal Structure of Chimeric Antibody C2H7 Fab in complex with a CD20 Peptide | |
Heteromer
| 167-183 | 100 | |
|